CA
RVMD icon

CoreCap Advisors’s Revolution Medicines RVMD Stock Holding History

CoreCap Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$93.8K Buy
457
+455
+22,750% +$90.2K ﹤0.01% 1127
2026
Q2 		$375 Buy
+2
New +$292 ﹤0.01% 2919

Other funds holding RVMD

FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
CGFA
Colton Groome Financial Advisors Asheville, North Carolina $427M AUM 13.21% 1-Year Est. Return
CFG
Cooper Financial Group Irvine, California $1.26B AUM 21.18% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
RW
RVW Wealth Los Angeles, California $1.56B AUM 16.49% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
BFS
Burkett Financial Services Rock Hill, South Carolina $331M AUM 14.93% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return

CoreCap Advisors's RVMD Position: Q3 2026 in Review

CoreCap Advisors increased its Revolution Medicines (RVMD) stake by 22,750% in Q3 2026, buying an estimated $90.2K and bringing the position to 457 shares worth $93.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1127.

CoreCap Advisors first reported a position in RVMD in Q2 2026 and has held it in 2 quarters since. 17 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • CoreCap Advisors held 457 shares of Revolution Medicines worth $93.8K as of Q3 2026.
  • CoreCap Advisors bought 455 Revolution Medicines shares in Q3 2026, an estimated $90.2K.
  • Revolution Medicines made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #1127 holding.
  • CoreCap Advisors first reported a position in Revolution Medicines in Q2 2026 and has held it in 2 quarters since.
  • 17 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.